(Total Views: 376)
Posted On: 04/18/2019 9:57:41 PM
Post# of 72441
There is one metric by which we can judge the level of success of the B-OM phase 2 trial. That metric will be the size of the deal that results from it. The judge will be the partnering pharmaceutical company.
If we get a $30M upfront we will know that is what the best offer is. The trial would not be considered a HUGE success then.
If we get $100M+ upfront we will know that a BP judged it to be a huge success.
The opinions of shareholders, management, and pundits do not matter one little bit compared to those of the potential suitors. Time will tell.
If we get a $30M upfront we will know that is what the best offer is. The trial would not be considered a HUGE success then.
If we get $100M+ upfront we will know that a BP judged it to be a huge success.
The opinions of shareholders, management, and pundits do not matter one little bit compared to those of the potential suitors. Time will tell.
(0)
(1)Scroll down for more posts ▼
